Is HCA Healthcare Stock Outperforming the Dow?
Singleron Biotechnologies Partners With the Human Cell Atlas (HCA) to Enhance Access to Single Cell Analysis Globally
COLOGNE, Germany, June 18, 2024 /PRNewswire/ -- Singleron Biotechnologies announced a partnership with the Human Cell Atlas (HCA) to help accelerate the adoption of single cell sequencing globally. S
Compelling Reasons to Hold on to HCA Healthcare (HCA) Stock
Peering Into HCA Healthcare's Recent Short Interest
HCA Healthcare's (NYSE:HCA) short percent of float has risen 12.06% since its last report. The company recently reported that it has 3.02 million shares sold short, which is 1.58% of all regular share
BofA Securities Maintains HCA Healthcare(HCA.US) With Buy Rating
BofA Securities analyst Kevin Fischbeck maintains $HCA Healthcare(HCA.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 61.9% and a total average return of 3.8% over
HCA Healthcare To Go Ex-Dividend On June 14th, 2024 With 0.66 USD Dividend Per Share
June 12th (Eastern Time) - $HCA Healthcare(HCA.US)$ is trading ex-dividend on June 14th, 2024.Shareholders of record on June 14th, 2024 will receive 0.66 USD dividend per share on June 28th, 2024. The
Argus Raises HCA Healthcare's Price Target to $400 From $390
02:31 PM EDT, 06/10/2024 (MT Newswires) -- Argus Raises HCA Healthcare's Price Target to $400 From $390 Price: 340.95, Change: +3.51, Percent Change: +1.04
Why HCA Healthcare (HCA) Is a Top Value Stock for the Long-Term
Wolfe Research Adjusts Price Target on HCA Healthcare to $358 From $357
HCA Healthcare (HCA) has an average rating of outperform and price targets ranging from $285 to $396, according to analysts polled by Capital IQ. Price: 335.56, Change: -1.26, Percent Change: -0.37
Express News | HCA Healthcare Inc : Jefferies Raises Target Price to $390 From $350
HCA Healthcare, Inc.'s (NYSE:HCA) P/E Still Appears To Be Reasonable
With a median price-to-earnings (or "P/E") ratio of close to 17x in the United States, you could be forgiven for feeling indifferent about HCA Healthcare, Inc.'s (NYSE:HCA) P/E ratio of 16.1x. While
Jefferies Raises HCA Healthcare's Price Target to $390 From $350
HCA Healthcare (HCA) has an average rating of outperform and price targets ranging from $285 to $396, according to analysts polled by Capital IQ. Price: 336.67, Change: -0.24, Percent Change: -0.07
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today
HCA Healthcare (NYSE:HCA) has outperformed the market over the past 5 years by 7.71% on an annualized basis producing an average annual return of 20.46%. Currently, HCA Healthcare has a market capital
HCA Healthcare Announces HCA Healthcare Foundation's $1 Million Grant to the Consortium of Florida Education Foundations
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that the HCA Healthcare Foundation, through its Healthier Tomorrow Fund, will donate $1 million over the next three
Strong Demand Pushed HCA Healthcare (HCA) in Q1
The Best Place to Live in Tennessee
Goldman Sachs Adjusts Price Target on HCA Healthcare to $340 From $311
HCA Healthcare (HCA) has an average rating of outperform and price targets ranging from $285 to $396, according to analysts polled by Capital IQ. Price: 334.98, Change: -0.12, Percent Change: -0.04
HCA Healthcare Is Maintained at Neutral by JP Morgan
HCA Healthcare Is Maintained at Neutral by JP Morgan
Express News | JP Morgan Maintains Neutral on HCA Healthcare, Raises Price Target to $332
HCA Healthcare On Track for Record High Close -- Data Talk
HCA Healthcare Inc (HCA) is currently at $334.92, up $9.79 or 3.01% --Would be new all-time high (Based on available data back to March 10, 2011) --Would be the first record close since March 28, 20
No Data